Proqr Therapeutics N.V.
SEC CIK 1612940 · PRQR · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Filius Bart | Director | filed 2026 - 2026 |
| Hinsch Gylvin Lykke | Director | filed 2026 - 2026 |
| Shannon James Samuel | Director | filed 2026 - 2026 |
| Lawton Alison Frances | Director | filed 2026 - 2026 |
| Heggie Theresa | Director | filed 2026 - 2026 |
| Platenburg Gerardus Johannes | Director · Chief Scientific Officer | filed 2026 - 2026 |
| Carreno-Gomez Begona | Director | filed 2026 - 2026 |
| Maier Martin Alexander | Director | filed 2026 - 2026 |
| de Boer Daniel Anton | Director · Chief Executive Officer | filed 2026 - 2026 |
| Valerio Domenico | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hom Dennis | Chief Financial Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.